• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV Back to Search Results
Catalog Number 06C29-27
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/11/2019
Event Type  malfunction  
Manufacturer Narrative
Patient information, patient identifier: multiple = 936351018140, 936351908140, 935252468140 and 930553348140.All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6c29 that has a similar product distributed in the us, list number 6l27.
 
Event Description
The customer reported multiple false reactive architect havab-igg results.The samples were retested and generated non-reactive results.The following initial and retest results were provided: sample id 936351018140: 1.04 s/co and retest 0.82 s/co.Sample id 936351908140: 1.05 s/co and retest 0.24 s/co.Sample id 935252468140: 1.46 s/co and retests 0.39, 0.42, 1.20 s/co.Sample id 930553348140: 1.23 s/co and retest 0.28 s/co.No impact to patient management was reported.
 
Manufacturer Narrative
A review of complaint activity for the architect havab igg assay determined there is slightly elevated complaint activity for lot 03405be00.The tracking and trending report review did not identify any trends.Field data for the architect havab igg assay was reviewed as well as the performance of the likely cause lot, 03405be00.The review showed that the median and the standard deviations (sds) to cutoff of the negative population for lot 03405be00 was within established baselines.Therefore, the performance of the likely cause lot was determined to not be compromised.Manufacturing documentation was reviewed, and no issues were identified.Additionally, labeling was reviewed and sufficiently addresses the customers issue.Based on the investigation, no systemic issue or deficiency of the architect havab igg assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-IGG
Type of Device
IGG ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9163537
MDR Text Key189496815
Report Number3002809144-2019-00589
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2020
Device Catalogue Number06C29-27
Device Lot Number03405BE00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/11/2019
Initial Date FDA Received10/07/2019
Supplement Dates Manufacturer Received11/21/2019
Supplement Dates FDA Received11/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LN 03M74-97,; ARCHITECT I2000SR ANALYZER, LN 03M74-97,; SERIAL (B)(4).; SERIAL (B)(4).
-
-